Agreed Hurst.
LTHs don’t need to worry,
I’m building a position, listening to the RNSs.
ATB
Sheppy- guessing that’s where the dog analogy comes from. Are you aware of the sector this share is in and the reasons as to why the SP has dropped? I’ll tell you. It’s due to the very long time scales that it takes to complete the trials to ensure that safety and efficacy is present. It has been known to take 10 years to bring a drug to the market. Obviously this is not a new drug, but a platform, that will take time to prove its worth. Along the way, these trials will be very expensive which means raising money to invest in the processes. This will affect the SP, as with investor sentiment and patience, or lack of it when the data isn’t immediately there. There will be positive news and then news which will affect confidence. Nevertheless, if investors believe in the science they will invest for the LONG TERM. This means another 2-3 years from now! If you don’t have the patience or belief you should sell your shares and move to a company or sector that gives quicker returns or a savings ISA.
The returns here could be huge, IF everything goes to plan. I, for one, will read the RNSs and follow data and qualitative comments in there.
Just saying…
Many thanks for the link, much appreciated.
Unfortunately my close friend has just phoned me tonight to say he has cancer in his throat.
They can’t operate, but have offered radio and chemotherapy for 5 days for 7 weeks.
Is there any point him contacting Avacta to see if he can join a trial to have a larger dosage and hopefully tumour shrinkage or does it have to come through a physician?
Thanks for any sensible advice.
The only offer showing is from 19/10/22 when shares were offered at 0.95p
II
I just saw the email I received at 5pm yesterday, informing me of the company action . I looked this morning in II and it had gone, so missed the moment.
Very naughty and designed to enable cheap shares to be scooped by large investment platforms .
Agreed. Nothing has changed for me. It was guaranteed a raise would come at some point anyway to finance the expensive and extensive trials.
Will have a look in September to see what’s happening with P2.
Nobody wins or loses until you sell.
As WB said, buy low sell high.
Snap the cheap shares up and follow the science.
Good luck LTHs
RNS’s are facts. They don’t lie, otherwise there would be serious repercussions.
So look at the information in the most recent RNS and decide if this is a potential huge opportunity or if you are impatient and are unable to wait until 2026-7 then sell sharpish, imo.
An interesting journey ahead!
You know nothing. This company deals in things way beyond common sense. The only thing people should take notice of are the key dates identified in the RNS.
This was always going to be a rocky road.
Share prices don’t go up in straight lines.
If you believe the science keep buying.
Truant
Are you saying you had insider information?
If so, do you understand the implications that carries :(
This was to be expected, although biggest hit to my trust of AS is the following:
‘anticipate commencing a potential Phase 3 trial in Q1 2026 for AVA6000 (also subject to funding and regulatory approval).’
I think he was quoted as saying we wouldn’t need a P3 trial?
Has anyone got the link pls as missed it yesterday?
Watching - have you got a link to the podcast pls, as missed it yesterday.
Thanks
Just a small delayed buy of £400k
No further market sensitive news provided on Wednesday, so hoping for some further data snippets from latest cohort, on Monday or Tuesday.
GLA
This is why we are invested.
GLA
Important updates are known.
Good luck trading between now and then.
Good luck all LTHs
Significantly higher levels released in the tumour…..